BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 10917546)

  • 1. Cyclooxygenase-2 overexpression correlates with tumour recurrence, especially haematogenous metastasis, of colorectal cancer.
    Tomozawa S; Tsuno NH; Sunami E; Hatano K; Kitayama J; Osada T; Saito S; Tsuruo T; Shibata Y; Nagawa H
    Br J Cancer; 2000 Aug; 83(3):324-8. PubMed ID: 10917546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between COX-2 expression and clinicopathological features of colorectal cancers.
    Zhan J; Liu JP; Zhu ZH; Yao HR; Chen CY
    Chin Med J (Engl); 2004 Aug; 117(8):1151-4. PubMed ID: 15361286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased cyclooxygenase-2 expression in large flat colorectal tumors (laterally spreading tumors).
    Yamashita K; Arimura Y; Shimizu H; Takahashi H; Endo T; Imai K; Yamano H
    J Gastroenterol; 2003; 38(1):69-73. PubMed ID: 12560924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of cyclooxygenase-2 in primary superficial bladder cancer tissue may predict risk of its recurrence after complete transurethral resection.
    Okajima E; Uemura H; Ohnishi S; Tanaka M; Ohta M; Tani M; Fujimoto K; Ozono S; Okajima E; Hirao Y
    Aktuelle Urol; 2003 Jul; 34(4):256-8. PubMed ID: 14566678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of cyclooxygenase-2 correlates with advanced stages of colorectal cancer.
    Zhang H; Sun XF
    Am J Gastroenterol; 2002 Apr; 97(4):1037-41. PubMed ID: 12003384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of haematogenous metastasis of colon cancer in mice by a selective COX-2 inhibitor, JTE-522.
    Tomozawa S; Nagawa H; Tsuno N; Hatano K; Osada T; Kitayama J; Sunami E; Nita ME; Ishihara S; Yano H; Tsuruo T; Shibata Y; Muto T
    Br J Cancer; 1999 Dec; 81(8):1274-9. PubMed ID: 10604722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potential for a selective cyclooxygenase-2 inhibitor in the prevention of liver metastasis in human colorectal cancer.
    Yamauchi T; Watanabe M; Hasegawa H; Nishibori H; Ishii Y; Tatematsu H; Yamamoto K; Kubota T; Kitajima M
    Anticancer Res; 2003; 23(1A):245-9. PubMed ID: 12680220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subepithelial myofibroblasts express cyclooxygenase-2 in colorectal tubular adenomas.
    Adegboyega PA; Ololade O; Saada J; Mifflin R; Di Mari JF; Powell DW
    Clin Cancer Res; 2004 Sep; 10(17):5870-9. PubMed ID: 15355919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of cyclooxygenase-2 protein in human gastric carcinoma.
    Lim HY; Joo HJ; Choi JH; Yi JW; Yang MS; Cho DY; Kim HS; Nam DK; Lee KB; Kim HC
    Clin Cancer Res; 2000 Feb; 6(2):519-25. PubMed ID: 10690533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular basis of colorectal cancer - role of gastrin and cyclooxygenase-2.
    Hartwich J; Konturek SJ; Pierzchalski P; Zuchowicz M; Konturek PC; Bielański W; Marlicz K; Starzyńska T; Ławniczak M
    Med Sci Monit; 2001; 7(6):1171-81. PubMed ID: 11687726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of COX-2 protein in colorectal carcinoma and the clinical implication].
    Yao HB; Wu AG; Chen YJ; Tang BH
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Dec; 25(12):1524-8. PubMed ID: 16361154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of matrilysin and cyclooxygenase-2 in intestinal and colorectal neoplasms.
    Shattuck-Brandt RL; Lamps LW; Heppner Goss KJ; DuBois RN; Matrisian LM
    Mol Carcinog; 1999 Mar; 24(3):177-87. PubMed ID: 10204802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microvessel density, cyclo-oxygenase 2 expression, K-ras mutation and p53 overexpression in colonic cancer.
    Liang JT; Huang KC; Jeng YM; Lee PH; Lai HS; Hsu HC
    Br J Surg; 2004 Mar; 91(3):355-61. PubMed ID: 14991639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of COX-2 immunohistochemical expression evaluated by quantitative image analysis in colorectal cancer.
    Zafirellis K; Agrogiannis G; Zachaki A
    APMIS; 2008 Oct; 116(10):912-22. PubMed ID: 19132985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COX-2: a molecular target for colorectal cancer prevention.
    Brown JR; DuBois RN
    J Clin Oncol; 2005 Apr; 23(12):2840-55. PubMed ID: 15837998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COX-2, NSAIDs and human neoplasia. Part I: Colorectal neoplasms.
    Nasir A; Fernandez PM; Chughtai OR; Kaiser HE
    In Vivo; 2002; 16(6):501-9. PubMed ID: 12494894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human colorectal adenomas demonstrate a size-dependent increase in epithelial cyclooxygenase-2 expression.
    Elder DJ; Baker JA; Banu NA; Moorghen M; Paraskeva C
    J Pathol; 2002 Dec; 198(4):428-34. PubMed ID: 12434411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cyclooxygenase(COX)-2-inhibition in the prevention and treatment of colorectal carcinoma].
    Tuynman JB; Hulscher JB; Steller EP; van Lanschot JJ; Richel DJ
    Ned Tijdschr Geneeskd; 2003 Nov; 147(45):2207-12. PubMed ID: 14640057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cyclooxygenase-2-expression in bladder cancer: tumor-biological and clinical implications].
    Wülfing C; Eltze E; Von Struensee D; Wülfing P; Bode ME; Bettendorf O; Piechota H; Hertle L
    Aktuelle Urol; 2004 Aug; 35(4):331-8. PubMed ID: 15459875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interstitial cell cyclooxygenase-2 expression is associated with increased angiogenesis in human sporadic colorectal adenomas.
    Chapple KS; Scott N; Guillou PJ; Coletta PL; Hull MA
    J Pathol; 2002 Dec; 198(4):435-41. PubMed ID: 12434412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.